Testing a cognitive assessment tool for ECT patients
Part of Brain & nervous system, Mental health clinical trials.
This study evaluates a cognitive assessment tool (ECCA) in Turkish patients who are receiving electroconvulsive therapy (ECT), a brain-stimulation treatment for severe depression or other psychiatric conditions. Researchers want to see how well this assessment works and compare it to other existing tests.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 18 and 65 years old
- You have been diagnosed with a condition that your doctor thinks would benefit from ECT (electroconvulsive therapy), based on standard psychiatric diagnostic criteria
- You can read and write in Turkish
- You do not have intellectual disability or significant cognitive impairments before starting treatment
- You do not have a history of neurological disease (such as stroke, Parkinson's, or epilepsy)
- You do not have dementia or substance abuse issues
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at how ECT affects brain activity and inflammation in older adults with depression. It may help researchers understand why ECT works and improve treatment.
This trial tests a new type of electric brain stimulation, called FEAST, as a treatment for severe depression. It aims to see if it can help improve mood with potentially fewer side effects than standard electroconvulsive therapy (ECT).
This trial studies better ways to deliver ECT (electroconvulsive therapy) for people with difficult-to-treat depression, including some people with bipolar depression. You may be offered an ECT strategy that’s tailored to your situation, with the goal of improving outcomes and reducing problems.
This study measures changes in your blood and/or body chemistry while you receive electroconvulsive therapy (ECT) for a severe mood episode. The goal is to understand biological signals related to ECT and treatment-resistant depression, which may help improve future care.
This trial follows people who have been referred for electroconvulsive therapy (ECT), a treatment used for certain severe mental health conditions. The study aims to learn about how ECT is used in real-world care and what outcomes may look like for patients.
This study looks at how to best set the electrical stimulation for electroconvulsive therapy (ECT), a treatment for severe depression and other mental health conditions. The goal is to improve how well ECT works while possibly reducing side effects.
Hear when a new Cognitive Assessment trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.